Luther King Capital Management (LKCM)
CSTL icon

Luther King Capital Management (LKCM)’s Castle Biosciences CSTL Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,481
Closed -$806K – 596
2023
Q1 		$806K Sell
35,481
-825
-2% -$20.2K ﹤0.01% 411
2022
Q4 		$855K Sell
36,306
-9,540
-21% -$221K ﹤0.01% 394
2022
Q3 		$1.2M Hold
45,846
– – 0.01% 353
2022
Q2 		$1.01M Sell
45,846
-60,254
-57% -$1.4M 0.01% 387
2022
Q1 		$4.76M Sell
106,100
-2,930
-3% -$121K 0.02% 204
2021
Q4 		$4.67M Buy
109,030
+19,940
+22% +$1.04M 0.02% 213
2021
Q3 		$5.92M Buy
89,090
+4,886
+6% +$344K 0.03% 186
2021
Q2 		$6.17M Buy
84,204
+4,224
+5% +$279K 0.03% 185
2021
Q1 		$5.47M Buy
79,980
+35,140
+78% +$2.64M 0.03% 188
2020
Q4 		$3.01M Sell
44,840
-1,360
-3% -$73.7K 0.02% 236
2020
Q3 		$2.38M Buy
46,200
+11,365
+33% +$506K 0.02% 240
2020
Q2 		$1.31M Buy
+34,835
New +$1.19M 0.01% 290

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Luther King Capital Management (LKCM)'s CSTL Position: Q2 2023 in Review

Luther King Capital Management (LKCM) sold out of Castle Biosciences (CSTL) in Q2 2023, closing a stake of 35,481 shares — an estimated $806K sold.

Luther King Capital Management (LKCM) first reported a position in CSTL in Q2 2020 and held it in 12 quarters. The position peaked at $6.17M in Q2 2021. 130 funds tracked by Wall St. Rank hold CSTL as of Q2 2023.

  • Luther King Capital Management (LKCM) reported no remaining Castle Biosciences position as of Q2 2023 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 35,481 Castle Biosciences shares in Q2 2023, an estimated $806K.
  • Luther King Capital Management (LKCM) first reported a position in Castle Biosciences in Q2 2020 and held it in 12 quarters.
  • Luther King Capital Management (LKCM)'s Castle Biosciences position peaked at $6.17M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2023.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2023, filed 10 Aug 2023.